Growth, Shrinking, and Breaking of Pluronic Micelles in the Presence of Drugs and/or β-Cyclodextrin, a Study by Small-Angle Neutron Scattering and Fluorescence Spectroscopy
Authors:
- 14 May 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 26 (13) , 10561-10571
Abstract
The associative structures between F127 Pluronic micelles and four drugs, namely, lidocaine (LD), pentobarbital sodium salt (PB), sodium naproxen (NP), and sodium salicylate (SAL), were studied by small-angle neutron scattering (SANS). Different outcomes for the micellar aggregates are observed, which are dependent on the chemical nature of the drug and the presence of charge or otherwise: the micelles grow with LD, are hardly modified with PB, and decrease in size with both NP and SAL. The partition coefficient, determined by fluorescence spectroscopy, is directly correlated to the amount of charge, following NP ≈ SAL < PB < LD. All drugs are found to lie at the interfacial layer, with a slightly deeper localization of LD and more superficial for PB. All drugs can form inclusion complexes with heptakis(2,6-di-O-methyl) β-cyclodextrin (hep2,6 β-CD). Hep2,6 β-CD, as shown in previous studies (Joseph, J.; Dreiss, C. A.; Cosgrove, T. Langmuir, 2008, 24, 10005−10010; Dreiss, C. A.; Nwabunwanne, E.; Liu, R.; Brooks, N. J. Soft Matter, 2009, 5, 1888−1896), is also able to form a complex with F127, resulting in micellar breakup. In the ternary mixtures, a fine balance of forces is involved, which results in drastic micellar changes, as observed from the SANS patterns. Depending on the ratio of drug, polymer, and hep2,6 β-CD and the nature of the interactions (which is directly linked to the drug chemical structure), the presence of drug either hinders micellar breakup by β-CD (at high enough concentration of LD or PB) or leads to micellar growth (NP). These effects are mainly attributed to a preferential drug/β-CD interaction (except for PB), which, at least in the conditions studied here, explains the higher β-CD concentration needed for micellar breakup to occur.Keywords
This publication has 50 references indexed in Scilit:
- Assembling and de-assembling micelles: competitive interactions of cyclodextrins and drugs with PluronicsSoft Matter, 2009
- Stretching a Polymer Brush by Making in Situ Cyclodextrin Inclusion ComplexesLangmuir, 2008
- Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Polymeric micelles for oral drug delivery: Why and howPure and Applied Chemistry, 2004
- Amphiphilic block copolymers for drug deliveryJournal of Pharmaceutical Sciences, 2003
- Polymeric Micelles for Delivery of Poorly Water-Soluble CompoundsCritical Reviews™ in Therapeutic Drug Carrier Systems, 2003
- Pluronic® block copolymers as novel polymer therapeutics for drug and gene deliveryJournal of Controlled Release, 2002
- Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug deliveryAdvanced Drug Delivery Reviews, 2002
- Block copolymer micelles for drug delivery: design, characterization and biological significanceAdvanced Drug Delivery Reviews, 2001
- Poly(ethylene oxide)poly(propylene oxide)poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modelingColloids and Surfaces A: Physicochemical and Engineering Aspects, 1995